Stage IV lung cancer survivor Frank Sierawski shares what it was like being diagnosed with cancer at age 35 and how he learned to cope with the diagnosis by living in the moment.
In this podcast, 4 experts discuss the first-ever targeted therapies approved for people with non-small cell lung cancer with an epidermal growth factor receptor (EGFR) exon 20 insertion mutation, including how they work and what they mean for people with this type of cancer.
Immunotherapy Combinations for Treating Metastatic Melanoma and Using Technology to Find and Treat Symptoms Early: The ASCO Plenary Series
Research from the first ASCO Plenary Series presentation has arrived. Read more about studies on using immunotherapy to treat metastatic melanoma and how technology can be used to find and manage symptoms during cancer treatment.
2021 ASCO Annual Meeting Research Round Up: Advances in Treating Brain Tumors, Esophageal Cancer, and Colorectal Cancer
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting on brain tumors, esophageal cancer, and colorectal cancer.
2021 ASCO Annual Meeting Research Round Up: Advances in Treating Lung Cancer, Breast Cancer, and Sarcoma
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting in lung cancer, breast cancer, and sarcoma and describe what this research means for people with cancer.
ASCO’s 2021 Advance of the Year highlights how progress in the treatment of gastrointestinal (GI) cancers is driven by molecular testing of tumors.
Dr. Neeraj Agarwal discusses 3 clinical trials presented at the 2020 ESMO Virtual Congress that studied new treatments for advanced kidney cancer, prostate cancer, and bladder cancer.
In this podcast, Cancer.Net Associate Editors share exciting research from the ASCO20 Virtual Scientific Program.
ASCO20 Virtual Scientific Program: Immunotherapy for Colorectal Cancer, Maintenance Therapy for Bladder Cancer, Precision Medicine in Childhood Cancers, Treatment for Gestational Trophoblastic Disease, and Targeted Therapy for Non-Small Cell Lung Cancer
Read research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on immunotherapy for metastatic colorectal cancer and gestational trophoblastic disease, maintenance therapy for advanced bladder cancer, the potential of precision medicine for childhood cancers, and targeted therapy after surgery for EGFR-positive non-small cell lung cancer.
Programa científico virtual de ASCO20: Inmunoterapia para el cáncer colorrectal metastásico, terapia de mantenimiento para el cáncer de vejiga, medicina de precisión para el cáncer infantil, inmunoterapia para la ETG y terapia dirigida para el NSCLC
Lea los puntos destacados de la investigación del programa científico virtual ASCO20 que se acaban de publicar. Incluyen estudios sobre inmunoterapia para el cáncer colorrectal metastásico y la enfermedad trofoblástica gestacional, terapia de mantenimiento para el cáncer de vejiga avanzado, el potencial de la medicina de precisión para el cáncer infantil y la terapia dirigida después de la cirugía por EGFR (receptor del factor de crecimiento epidérmico), positivo de cáncer de pulmón de células no pequeñas.